MedTrace Logo

Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis

NCT04920851 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2021-06-10

No results posted yet for this study

Summary

In this retrospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in COVID-19 ICU patients with or without sepsis.

Conditions

  • INTERLEUKIN 6

Interventions

DEVICE

cytokine hemadsorption

to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in COVID-19 ICU patients with or without sepsis.

Sponsors & Collaborators

  • Derince Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-10
Primary Completion
2021-07-05
Completion
2021-07-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04920851 on ClinicalTrials.gov